LifeStance Health EBITDA 2020-2025 | LFST
LifeStance Health ebitda from 2020 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
|
LifeStance Health Annual EBITDA (Millions of US $) |
|
|---|---|
| 2025 | $80 |
| 2024 | $41 |
| 2023 | $-107 |
| 2022 | $-139 |
| 2021 | $-230 |
| 2020 | $47 |
| 2019 | $22 |
|
LifeStance Health Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-12-31 | $32 |
| 2025-09-30 | $21 |
| 2025-06-30 | $11 |
| 2025-03-31 | $16 |
| 2024-12-31 | $16 |
| 2024-09-30 | $16 |
| 2024-06-30 | $3 |
| 2024-03-31 | $6 |
| 2023-12-31 | $-10 |
| 2023-09-30 | $-54 |
| 2023-06-30 | $-28 |
| 2023-03-31 | $-14 |
| 2022-12-31 | $-27 |
| 2022-09-30 | $-20 |
| 2022-06-30 | $-43 |
| 2022-03-31 | $-49 |
| 2021-12-31 | $-98 |
| 2021-09-30 | $-110 |
| 2021-06-30 | $-34 |
| 2021-03-31 | $12 |
| 2020-12-31 | $12 |
| 2020-09-30 | $14 |
| 2020-06-30 | $10 |
| 2020-03-31 | $8 |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $2.735B | $1.251B |
| LifeStance Health Group Inc. is provider of virtual and in-person outpatient mental health care for children, adolescents and adults of mental health conditions. LifeStance Health Group Inc. is based in SCOTTSDALE, Ariz. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $34.042B | 17.17 |
| Quest Diagnostics (DGX) | United States | $23.013B | 21.00 |
| Elanco Animal Health (ELAN) | United States | $12.486B | 26.18 |
| Encompass Health (EHC) | United States | $11.082B | 20.17 |
| DaVita (DVA) | United States | $9.950B | 13.72 |
| Chemed (CHE) | United States | $6.703B | 23.54 |
| Option Care Health (OPCH) | United States | $5.622B | 23.93 |
| RadNet (RDNT) | United States | $5.365B | 183.00 |
| Addus HomeCare (ADUS) | United States | $2.103B | 21.72 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.657B | 20.87 |
| U.S Physical Therapy (USPH) | United States | $1.322B | 33.44 |
| Pennant (PNTG) | United States | $1.106B | 36.75 |
| Astrana Health (ASTH) | United States | $1.057B | 98.84 |
| Daxor (DXR) | United States | $0.062B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.038B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |